EXCLUSIVE: Russia, after approving Japanese COVID-19 drug, to roll out 'game changer' next week via A_Osborn
FILE PHOTO: Paramedics and members of the Emergencies Ministry wearing personal protective equipment push a stretcher into an ambulance while transporting a patient amid the coronavirus disease outbreak in the city of Tver, Russia May 28, 2020. REUTERS/Tatyana Makeyeva/File Photo
A new antiviral drug from Gilead called remdesivir has shown some promise in small efficacy trials against COVID-19 and is being given to patients by some countries under compassionate or emergency use rules. Japan has been trialling the same drug, known there as Avigan. It has won plaudits from Prime Minister Shinzo Abe and $128 million in government funding, but has yet to be approved for use.Russia's PM says 'grounds for cautious optimism' in coronavirus fightDmitriev said clinical trials of the drug had been conducted involving 330 people, and had shown that it successfully treated the virus in most cases within four days.
Success in small small-scale, early-stage trials is no guarantee of success in later, more comprehensive trials. “We believe this is a game changer. It will reduce strain on the healthcare system, we’ll have fewer people getting into a critical condition,” said Dmitriev. “We believe that the drug is key to resuming full economic activity in Russia.”
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Exclusive: Russia, after approving Japanese COVID-19 drug, to roll out 'game changer' next weekRussia will start administering its first approved antiviral drug to treat coronavirus patients next week, its state financial backer told Reuters, a move it described as 'a game changer' that should speed a return to normal economic life.
Weiterlesen »
Russia Approves Flu Drug’s Use Against Covid-19Russia’s Ministry of Health on Saturday approved a flu drug for use in fighting coronavirus after officials said preliminary testing showed hospitalized patients who took the pills recovered more quickly.
Weiterlesen »
Hong Kong reports first local COVID-19 cases in two weeksHong Kong has confirmed its first locally transmitted coronavirus cases in more than two weeks, fuelling concerns over its spread as restrictions on movement are relaxed.
Weiterlesen »
South Korea's Celltrion aims to start in-human COVID-19 drug trial in JulySouth Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated an up to 100-fold reduction in viral load of the disease in animal testing, saying it aims to start in-human clinical trials in late July.
Weiterlesen »
'I Just Couldn't Let Her Die Alone': Nurse FaceTimes COVID-19 Patient Through Final HoursCommentary: Linda Lombardi knew that her former patient had no family or close friends. So she used FaceTime to stay with her during her final hours in a special palliative care ward for COVID-19 patients. 'I just couldn't let her die alone,' she says.
Weiterlesen »